Portfolio Update

RNS Number : 7930C
Intl. Biotechnology Trust PLC
19 November 2009
 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC    

                

                    

Portfolio update as at 31 October 2009                    



Total Net Assets

£91.9m

NAV per share

141.7p

Share Price

121.8p 

Total value of unquoted investments

£18.2m

Total number of portfolio companies

58

Cash

9%

Cash committed and reserved to unquoted investments

15%

Portfolio companies with < 1 year of cash

15%


                    

Top Ten Holdings

                                    

Company Name

NAV

Market Value

Micromet 

7.92

7,276,794

Celgene

6.31

5,799,732

Amgen

5.64

5,180,290

HSBC Sterling Liquid Fund B shares

4.68

4,300,645

Gilead Sciences

4.34

3,984,233

Prime Rate Sterling Liquidity Class 3 

3.81

3,502,037

Alexion Pharmaceuticals

3.47

3,188,462

Genzyme

3.06

2,807,900

Wright Medical

2.89

2,652,989

Halozyme Therapeutics

2.24

2,056,948


-----------

--------------

Total

44.36

40,750,030


Geographical Allocation

%

United States

75

Europe

14

Cash

9

Australia

2


-----------

Total

100


                                    

Quoted/Unquoted allocation

%

Quoted

71

Unquoted

20

Cash

9


-----------


100

        


BNP Paribas Secretarial Services Limited

Company Secretary


19 NOVEMBER 2009


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUBSBDBDBBGGCC
UK 100